Tumor-initiating CSCs in breast cancer tissue may be a result of oncogenic mutations in normal stem cells or progenitors; increased levels of HSP70 are necessary to provide their ‘stemness’, contributing to tumor progression [82,96]. This evidence concerns the gene HSPA1A and breast cancer.